SAETTA, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 19.360
AS - Asia 5.822
EU - Europa 4.374
AF - Africa 1.639
SA - Sud America 1.398
OC - Oceania 161
Continente sconosciuto - Info sul continente non disponibili 99
Totale 32.853
Nazione #
US - Stati Uniti d'America 18.511
SG - Singapore 1.733
CN - Cina 1.155
BR - Brasile 925
HK - Hong Kong 891
SE - Svezia 533
FI - Finlandia 530
DE - Germania 453
VN - Vietnam 444
IT - Italia 408
UA - Ucraina 278
FR - Francia 250
RU - Federazione Russa 199
GB - Regno Unito 184
PL - Polonia 169
NL - Olanda 119
IN - India 118
MX - Messico 94
TR - Turchia 90
IE - Irlanda 85
AR - Argentina 81
CI - Costa d'Avorio 80
EC - Ecuador 65
KR - Corea 65
ID - Indonesia 64
AT - Austria 63
ZA - Sudafrica 63
ES - Italia 60
JP - Giappone 57
AE - Emirati Arabi Uniti 56
CA - Canada 56
IQ - Iraq 56
EG - Egitto 55
AL - Albania 54
TN - Tunisia 54
AO - Angola 53
NP - Nepal 53
BE - Belgio 51
BY - Bielorussia 50
DZ - Algeria 49
IL - Israele 49
JM - Giamaica 49
RO - Romania 49
CW - ???statistics.table.value.countryCode.CW??? 48
LB - Libano 48
PH - Filippine 48
HR - Croazia 47
JO - Giordania 47
CZ - Repubblica Ceca 46
EE - Estonia 46
MA - Marocco 46
DK - Danimarca 45
GN - Guinea 45
PE - Perù 45
PK - Pakistan 45
SN - Senegal 45
AZ - Azerbaigian 44
BG - Bulgaria 44
KZ - Kazakistan 44
PA - Panama 44
SO - Somalia 44
UZ - Uzbekistan 44
AU - Australia 43
BZ - Belize 43
CD - Congo 43
LU - Lussemburgo 43
PS - Palestinian Territory 43
ZM - Zambia 43
CL - Cile 42
CO - Colombia 42
DO - Repubblica Dominicana 42
GF - Guiana Francese 42
GM - Gambi 42
ME - Montenegro 42
MU - Mauritius 42
MY - Malesia 42
MZ - Mozambico 42
NI - Nicaragua 42
TJ - Tagikistan 42
TW - Taiwan 42
XK - ???statistics.table.value.countryCode.XK??? 42
BA - Bosnia-Erzegovina 41
BB - Barbados 41
GE - Georgia 41
KE - Kenya 41
ML - Mali 41
TZ - Tanzania 41
VE - Venezuela 41
GR - Grecia 40
HU - Ungheria 40
LY - Libia 40
MD - Moldavia 40
NO - Norvegia 40
PR - Porto Rico 40
PY - Paraguay 40
RS - Serbia 40
BF - Burkina Faso 39
CH - Svizzera 39
CY - Cipro 39
DJ - Gibuti 39
Totale 30.933
Città #
Fairfield 2.538
Woodbridge 2.124
Ashburn 1.434
Chandler 1.400
Houston 1.370
Ann Arbor 1.344
Singapore 1.034
Jacksonville 1.010
Wilmington 896
Seattle 881
Hong Kong 863
Cambridge 807
Princeton 440
Boardman 412
Beijing 320
Dong Ket 278
Santa Clara 268
San Diego 251
Des Moines 240
Helsinki 205
Nanjing 171
Roxbury 168
Los Angeles 156
Munich 152
Medford 149
Bytom 119
Padova 94
Dublin 79
Ho Chi Minh City 74
Abidjan 73
São Paulo 70
Chicago 67
New York 60
Hefei 55
Turku 53
Buffalo 51
Hebei 50
London 49
Luanda 49
Shenyang 48
Nanchang 47
Dakar 45
Conakry 43
Jinan 43
Lusaka 43
Amman 42
Baku 42
Changsha 41
Falls Church 41
Managua 41
Panama City 41
Dushanbe 40
Bridgetown 39
Willemstad 39
Bamako 37
Tashkent 37
Vienna 37
Accra 36
Bishkek 36
Minsk 36
Kinshasa 35
Niamey 35
Ogden 35
Ulan Bator 35
Antananarivo 34
Castries 34
Djibouti 34
Kigali 34
Kingston 34
Nairobi 34
Norwalk 34
Podgorica 34
Tirana 34
Cayenne 33
Dallas 33
Jiaxing 33
Libreville 33
Praia 33
Riga 33
Tallinn 33
Montevideo 32
Salt Lake City 32
Zagreb 32
Dar es Salaam 31
Johannesburg 31
Kampala 31
Lima 31
Maputo 31
Brooklyn 30
Nassau 30
Nouakchott 30
Yerevan 30
Havana 29
Reykjavik 29
San Francisco 29
Tbilisi 29
Banjul 28
Cotonou 28
Hanoi 28
Harare 28
Totale 21.984
Nome #
Reduced apoptosis of CD8+ T-lymphocytes in the airways of smokers with mild/moderate COPD. 262
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment 220
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 219
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease 205
Immune inflammation and disease progression in idiopathic pulmonary fibrosis 201
Airway inflammation in childhood asthma 198
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 196
Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing 193
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 191
High viral frequency in children with gastroesophageal reflux-related chronic respiratory disorders. 189
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 188
AIRWAY MUCOSAL INFLAMMATION IN OCCUPATIONAL ASTHMA INDUCED BY TOLUENE DIISOCYANATE 179
Clinical and pathologic factors predicting future Asthma in wheezing children: A longitudinal study 178
COPD-related adenocarcinoma presents low aggressiveness morphological and molecular features compared to smoker tumours. 177
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. 175
Airway inflammation in severe chronic obstructive pulmonary disease 174
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology 173
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) 169
Alpha-1 antitrypsin deficiency: Beyond the protease/antiprotease paradigm 168
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 167
Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations. 165
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 160
Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence 159
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma. 158
Small airway morphology and lung function in the transition from normality to chronic airway obstruction 156
Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma 155
Quality standards for the management of bronchiectasis in Italy: A national audit 154
IN-VITRO EXPOSURE TO NITROGEN-DIOXIDE (NO2) DOES NOT ALTER BRONCHIAL SMOOTH-MUSCLE RESPONSIVENESS IN OVALBUMIN-SENSITIZED GUINEA-PIGS 153
AIRWAY WALL REMODELING AFTER CESSATION OF EXPOSURE TO ISOCYANATES IN SENSITIZED ASTHMATIC SUBJECTS 153
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 152
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 152
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 151
Airway inflammation in chronic obstructive pulmonary disease 150
MECHANISMS AND PATHOLOGY OF OCCUPATIONAL ASTHMA 147
EFFECT OF CESSATION OF EXPOSURE TO TOLUENE DIISOCYANATE (TDI) ON BRONCHIAL-MUCOSA OF SUBJECTS WITH TDI-INDUCED ASTHMA 146
Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease 146
Blood eosinophils relate to atopy and not to tissue eosinophils in wheezing children 146
Alpha-1 antitrypsin deficiency today: New insights in the immunological pathways 145
α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency 143
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department 143
An asthmatic patient with progressive lung dysfunction: a case of misdiagnosis. 142
Effect of inhalation of thermal water on airway inflammation in chronic obstructive pulmonary disease 142
Pathophysiology of the small airways 142
TOLUENE DIISOCYANATE-STIMULATED RELEASE OF ARACHIDONIC-ACID METABOLITES IN THE ORGAN BATH FROM GUINEA-PIG AIRWAYS 142
CD8 T-CELL CLONES PRODUCING INTERLEUKIN-5 AND INTERFERON-GAMMA IN BRONCHIAL-MUCOSA OF PATIENTS WITH ASTHMA INDUCED BY TOLUENE DIISOCYANATE 141
UP-REGULATION OF ADHESION MOLECULES IN THE BRONCHIAL MUCOSA OF SUBJECTS WITH CHRONIC OBSTRUCTIVE BRONCHITIS 141
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial 141
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline 141
LATE ASTHMATIC REACTIONS, AIRWAY INFLAMMATION AND CHRONIC ASTHMA IN TOLUENE-DIISOCYANATE-SENSITIZED SUBJECTS 140
CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome. 140
Ceramide Expression and Cell Homeostasis in Chronic Obstructive Pulmonary Disease. 139
Bronchiolitis obliterans organizing pneumonia (BOOP) in a child with mild-to-moderate asthma: evidence of mast cell and eosinophil recruitment in lung specimens 138
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 138
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 138
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 138
Increased activation of p38 MAPK in COPD 137
EFFECT OF SMOKING CESSATION ON AIRWAY INFLAMMATION IN CHRONIC-BRONCHITIS 137
IN-VITRO EXPOSURE OF GUINEA-PIG MAIN BRONCHI TO 2-CENTER-DOT-5 PPM OF NITROGEN-DIOXIDE DOES NOT ALTER AIRWAY SMOOTH-MUSCLE RESPONSE 136
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 136
AIRWAY EOSINOPHILIA IN CHRONIC-BRONCHITIS DURING EXACERBATIONS 136
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis 136
AIRWAY INFLAMMATION DURING LATE ASTHMATIC REACTIONS INDUCED BY TOLUENE DIISOCYANATE 135
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 135
ACTIVATED LYMPHOCYTES-T AND EOSINOPHILS IN THE BRONCHIAL-MUCOSA IN ISOCYANATE-INDUCED ASTHMA 134
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study 134
Evasion of copd in smokers. at what price? 133
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis 133
MAST-CELLS IN THE AIRWAY MUCOSA AND RAPID DEVELOPMENT OF OCCUPATIONAL ASTHMA INDUCED BY TOLUENE DIISOCYANATE 133
Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19 133
Up-regulated membrane and nuclear leukotriene B4 receptors in COPD 132
Epithelial damage and angiogenesis in the airways of children with asthma. 132
Expiratory pattern of newborn mammals. 132
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 131
Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis. 131
Mechanical aspects of chest wall distortion. 130
Risk Factors for Development and Severity of COVID-19 in COPD Patients 130
Air pollution exposure impairs airway epithelium IFN-β expression in pre-school children 130
Mast Cell Infiltration Discriminates Between Histopathological Phenotypes of Chronic Obstructive Pulmonary Disease. 129
Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate 129
Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI) 129
Predominant emphysema phenotype in chronic obstructive pulmonary disease patients 128
THE EFFECTS OF TOLUENE DIISOCYANATE AND OF CAPSAICIN ON HUMAN BRONCHIAL SMOOTH-MUSCLE IN-VITRO 128
To reg or not to reg: that is the question in COPD 128
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 127
EFFECTS OF INHALED BECLOMETHASONE ON AIRWAY RESPONSIVENESS IN OCCUPATIONAL ASTHMA - PLACEBO-CONTROLLED STUDY OF SUBJECTS SENSITIZED TO TOLUENE DIISOCYANATE 126
EFFECT OF BUMETANIDE ON TOLUENE DIISOCYANATE INDUCED CONTRACTIONS IN GUINEA-PIG AIRWAYS 126
The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma 126
[Relation between non-specific bronchial hyperreactivity, smoking, atopy and respiratory function conditions in non-asthmatic subjects]. 126
Fatal asthma in a subject sensitized to toluene diisocyanate. 126
Air Pollution Relates to Airway Pathology in Wheezing Children 126
Severity of airflow limitation is associated with severity of airway inflammation in smokers 125
Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children 124
Neutrophilic infiltration within the airway smooth muscle in patients with COPD 124
Exome sequencing reveals immune genes as susceptibility modifiers in a1-antitrypsin deficiency 124
IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease 123
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 123
Basi Strutturali della BPCO 122
FATAL ASTHMA ATTACK DURING AN INHALATION CHALLENGE WITH ULTRASONICALLY NEBULIZED DISTILLED WATER 122
ACTIVATED LYMPHOCYTES-T AND MACROPHAGES IN BRONCHIAL-MUCOSA OF SUBJECTS WITH CHRONIC-BRONCHITIS 122
Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression 121
Totale 14.779
Categoria #
all - tutte 110.393
article - articoli 96.466
book - libri 452
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.313
Totale 209.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.526 0 0 0 330 72 229 150 233 440 326 347 399
2021/20223.589 144 407 436 362 132 177 186 429 154 101 355 706
2022/20232.865 597 240 48 318 455 475 3 191 324 24 148 42
2023/20241.307 52 221 127 105 91 147 67 80 53 36 176 152
2024/20255.524 25 302 300 223 703 196 276 422 548 253 991 1.285
2025/20267.731 842 2.098 3.242 1.549 0 0 0 0 0 0 0 0
Totale 33.152